Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502956 | SCV000594490 | pathogenic | Distal arthrogryposis type 5D | 2016-06-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000171336 | SCV001831942 | likely pathogenic | not provided | 2020-05-13 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26752647, 23829171, 30131190) |
Revvity Omics, |
RCV000502956 | SCV003831374 | uncertain significance | Distal arthrogryposis type 5D | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV000502956 | SCV004801141 | uncertain significance | Distal arthrogryposis type 5D | 2024-03-14 | criteria provided, single submitter | research | |
Genomic Medicine Center of Excellence, |
RCV000171336 | SCV000221533 | likely pathogenic | not provided | flagged submission | research | ||
Biochemical Molecular Genetic Laboratory, |
RCV000502956 | SCV001133101 | pathogenic | Distal arthrogryposis type 5D | 2019-09-26 | no assertion criteria provided | clinical testing | |
Lupski Lab, |
RCV000502956 | SCV001167522 | likely pathogenic | Distal arthrogryposis type 5D | no assertion criteria provided | research |